BVMF/W2ST34 (BVMF/W2ST34)

Brazil Stock Exchange: BVMF/W2ST34 · BRL

R$49.3

+0.00 (0.0%)· Recorded snapshot

Market cap	152.6B
Revenue (ttm)	17.6B
Net income (ttm)	3.3B
EPS (ttm)	R$1.37
P/E (trailing)	36.0x
P/E (forward)	42.0x
Dividend	R$0.09 (0.18%)
Volume	0
Beta	1.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.6B
Net income (ttm): 3.3B
EPS (ttm): R$1.37
P/E (trailing): 36.0x
P/E (forward): 42.0x
Market cap: 152.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E42

P25 n/aP50 n/aP75 n/a

Trailing P/E36

P25 n/aP50 n/aP75 n/a

ROE21.2

P25 n/aP50 n/aP75 n/a

ROIC23.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/W2ST34 indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	10,800
Employees change	-600
Employees growth	-5.66%
Enterprise value	BRL 152B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1923
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRW2STBDR007
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	BRL 152.6B
Next earnings date	2026-10-29
Price	BRL 49.25
Price currency	BRL
Sector	Healthcare
SIC code	3060
Stock price date	2026-09-08
Symbol	bvmf/W2ST34
Website	https://www.westpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	44.41x
Average P/E ratio (3Y)	41.39x
Average P/E ratio (5Y)	41.8x
Earnings yield	2.78%
EV/Earnings	45.93x
EV/EBIT	33.21x
EV/EBITDA	27.64x
EV/FCF	64.71x
EV/Sales	8.33x
FCF / EV yield	1.55%
FCF yield	1.54%
Forward P/E	41.98x
Graham number	10.91812
Graham upside	-77.83%
Lynch fair value	BRL 5.34
Lynch upside	-89.16%
P/(FCF - SBC) ratio	69.35x
P/(OCF - SBC) ratio	47.07x
P/B ratio	9.93x
P/E ratio	36.03x
P/FCF ratio	64.99x
P/OCF ratio	45.02x
P/S ratio	8.67x
Price / tangible book value	10.33x
Price/EBITDA ratio	30.61x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.55%
EBITDA margin	28.34%
Effective tax rate	20.84%
FCF margin	12.87%
Gross margin	37.59%
Operating margin	24.55%
Pretax margin	23.76%
Profit margin	18.81%
Profit per employee	BRL 306,429
Profitable quarters	34
Profitable years	24
Revenue per employee	BRL 1.6M
ROA	12.77%
ROA (5Y)	12.28%
ROCE	24.41%
ROE	21.23%
ROE (5Y)	22.16%
ROIC	23.25%
ROIC (5Y)	27.23%
SBC / revenue	0.84%
Tax / revenue	4.95%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.87%
EPS growth (Q)	57.29%
EPS growth (QoQ)	40.47%
EPS growth 10Y	17.02%
EPS growth 3Y	6.28%
EPS growth 5Y	2%
EPS growth quarters	5
EPS growth years	1
FCF growth	19.6%
FCF growth (Q)	12.32%
FCF growth (QoQ)	86.14%
FCF growth 3Y	2.58%
FCF growth 5Y	6.09%
Gross profit growth	18.93%
Gross profit growth (Q)	18.04%
Gross profit growth 3Y	4.65%
Gross profit growth 5Y	3.29%
Net income growth	29.94%
Net income growth (Q)	52.86%
Net income growth (QoQ)	38.96%
Net income growth 3Y	4.53%
Net income growth 5Y	0.85%
Net income growth quarters	5
Net income growth years	1
OCF growth	-5.66%
OCF growth (Q)	-3.91%
OCF growth (QoQ)	52.82%
OCF growth 10Y	11.74%
OCF growth 3Y	-5.2%
OCF growth 5Y	2.73%
Operating income growth	31.07%
Operating income growth (Q)	52.1%
Operating income growth 3Y	3.66%
Operating income growth 5Y	3.78%
Revenue growth	12.55%
Revenue growth (Q)	8.69%
Revenue growth (QoQ)	0.25%
Revenue growth 10Y	8.61%
Revenue growth 3Y	5.09%
Revenue growth 5Y	4.85%
Revenue growth quarters	7
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -1B
Depreciation and amortization	BRL 691.1M
EBIT	BRL 4.3B
EBITDA	BRL 5B
EPS	BRL 1.37
Financing cash flow	BRL -3.8B
Free cash flow	BRL 2.3B
Free cash flow minus SBC	BRL 2.2B
Gross profit	BRL 6.6B
Income taxes	BRL 871.3M
Investing cash flow	BRL -430.4M
Net borrowing	BRL -8.1M
Net cash flow	BRL -851.6M
Net income	BRL 3.3B
Operating cash flow minus SBC	BRL 3.2B
Operating income	BRL 4.3B
Revenue	BRL 17.6B
Stock-based compensation	BRL 147.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 220.27
Debt / EBITDA	0.3
Debt / equity	0.1
Debt / FCF	0.67
Goodwill	BRL 584.1M
Interest coverage	1,668
Long-term assets	BRL 11.3B
Long-term liabilities	BRL 2.2B
Net cash (debt)	BRL 824.1M
Net cash / market cap	0.54%
Net cash growth	-51.12%
Net debt / EBITDA	-0.17
Net debt / equity	-0.05
Net debt / FCF	-0.35
Piotroski F-Score	6
Property, plant and equipment	BRL 9.5B
Shareholders' equity	BRL 15.4B
Tangible book value	BRL 14.8B
Tangible book value per share	BRL 211.75
Total assets	BRL 21B
Total cash	BRL 2.4B
Total debt	BRL 1.6B
Total liabilities	BRL 5.7B
WACC	10.33%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.83
Current assets	BRL 9.8B
Current liabilities	BRL 3.5B
Current ratio	2.82
Inventory turnover	4.7
Net working capital	BRL 3.8B
Quick ratio	1.88
Working capital	BRL 6.1B
Working capital turnover	14.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.48%
Dividend growth	-1.67%
Dividend growth (3Y)	7.05%
Dividend growth years	2
Dividend payment date	2026-11-25
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.09
Dividend yield	0.18%
Ex-dividend date	2026-11-10
Last dividend	BRL 0.03
Payout ratio	9.83%
Shareholder yield	1.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 45.13
1D price change	0%
1M price change	-4.05%
1M total return	-4.05%
1W price change	-4.05%
1W total return	-4.05%
1Y price change	29.47%
1Y return CAGR	29.76%
1Y total return	29.74%
20-day SMA	BRL 42.99
3M price change	10.62%
3M total return	10.67%
50-day SMA	BRL 41.20
52-week high	BRL 53.25
52-week high date	2026-07-23
52-week low	BRL 34.50
52-week low date	2026-02-03
5Y price change	-28.91%
5Y return CAGR	-6.43%
5Y total return	-28.28%
6M price change	42.75%
6M total return	42.88%
All-time high	BRL 75.51
All-time high date	2021-12-28
All-time low	BRL 30.70
All-time low date	2022-11-03
Average true range (ATR)	BRL 1.76
Average volume	36.6
Beta (5Y)	1.13
Change from 52-week high	-7.51%
Change from 52-week low	42.75%
Change from all-time high	-34.78%
Change from all-time low	60.42%
Change from open	0%
Day's gap	0%
High price	BRL 49.25
Low price	BRL 49.25
Monthly RSI	54.31
Open price	BRL 49.25
Previous close	BRL 49.25
Price vs 150-day SMA	9.12%
Price vs 20-day SMA	14.55%
Price vs 50-day SMA	19.54%
Relative volume	0.03
RSI	61.69
Sharpe ratio	0.17
Sortino ratio	0.29
Volume	0
Weekly RSI	52.22
YTD price change	20.83%
YTD total return	21.08%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69.8M
Shares change (QoQ)	-0.7%
Shares change (YoY)	-1.48%
Shares held by insiders	0.63%
Shares held by institutions	102.11%

Deeper analysis on BVMF/W2ST34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/W2ST34 report

Is a complete BVMF/W2ST34 research report available?

No complete published report is available for bvmf/W2ST34 (BVMF/W2ST34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/W2ST34 (BVMF/W2ST34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/W2ST34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/W2ST34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/W2ST34

Frequently asked questions